BIO Medical Applications Of Alabama is a medicare approved dialysis facility center in Huntsville, Alabama and it has 16 dialysis stations. It is located in Madison county at 8000 Charlotte Drive Sw, Huntsville, AL, 35802. You can reach out to the office of BIO Medical Applications Of Alabama at (256) 881-1133. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Alabama has the following ownership type - Profit. It was first certified by medicare in July, 2017. The medicare id for this facility is 012695 and it accepts patients under medicare ESRD program.
Name | BIO Medical Applications Of Alabama |
---|---|
Location | 8000 Charlotte Drive Sw, Huntsville, Alabama |
No. of Dialysis Stations | 16 |
Medicare ID | 012695 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
8000 Charlotte Drive Sw, Huntsville, Alabama, 35802 | |
(256) 881-1133 | |
Not Available |
NPI Number | 1174065056 |
Organization Name | Fresenius Medical Care Rocket City |
Doing Business As | Bio-medical Applications Of Alabama, Inc. |
Address | 8000 Charlotte Drive Sw Huntsville, Alabama, 35802 |
Phone Number | (256) 881-1133 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 11 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 11 |
Percentage of adult patients getting regular hemodialysis at the center | 100 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Alabama with elevated calcium levels.
Patients with hypercalcemia | 13 |
Hypercalcemia patient months | 13 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 15 |
Patient months included in arterial venous fistula and catheter summaries | 29 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 45 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
FMC North Alabama Location: 1311 N Memorial Pkwy #200, Huntsville, Alabama, 35801 Phone: (256) 536-8571 |